Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Salmaan A. Keshavjee, M.D., Ph.D.

Title
Institution
Department
Address
Phone
Fax
Other Positions
Title
Institution
Department
Title
Institution
Department
Title
Institution
Department

Mentoring
Civil Society Participation in HIV Policy: A Case Study in Malawi
International/Summer, 06/17/13 - 08/09/13
GAVI Fellowship
International, 05/02/11 - 06/24/11
Impact of Vaccines on the Reduction of Child Mortality in Developing Countries
International/Summer, 06/11/12 - 08/01/12
An Evaluation of GAVI-Supported Countries' Immunization Programs
International, 05/12/10 - 07/02/10
Strengthening Monitoring and Evaluation: A survey and comparative analysis of current mobile health technology pilots
Summer, 06/18/12 - 08/03/12
Ethnographic study of high-cost patients with multiple chronic illnesses.
Summer, 06/19/11 - 08/13/11

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Yuen CM, Majidulla A, Jaswal M, Safdar N, Malik AA, Khan AJ, Becerra MC, Keshavjee S, Lu C, Hussain H. Cost of Delivering 12-Dose Isoniazid and Rifapentine Versus 6 Months of Isoniazid for Tuberculosis Infection in a High-Burden Setting. Clin Infect Dis. 2021 09 07; 73(5):e1135-e1141. PMID: 33289039.
    Citations: 1     Fields:    
  2. Trout LJ, Weisman A, Miller JS, Kramer C, Keshavjee S, Kleinman AM, Kulkarni S, Baldwin T, Tobey ML, Buffey T, Harris NS. Siamit: A Novel Academic-Tribal Health Partnership in Northwest Alaska. Acad Med. 2021 Jul 13. PMID: 34261866.
    Citations:    Fields:    
  3. Yuen CM, Puma D, Millones AK, Galea JT, Tzelios C, Calderon RI, Brooks MB, Jimenez J, Contreras C, Nichols TC, Nicholson T, Lecca L, Becerra MC, Keshavjee S. Identifying barriers and facilitators to implementation of community-based tuberculosis active case finding with mobile X-ray units in Lima, Peru: a RE-AIM evaluation. BMJ Open. 2021 07 07; 11(7):e050314. PMID: 34234000.
    Citations:    Fields:    Translation:HumansCells
  4. Mantena S, Keshavjee S. Strengthening healthcare delivery with remote patient monitoring in the time of COVID-19. BMJ Health Care Inform. 2021 07; 28(1). PMID: 34289962.
    Citations:    Fields:    Translation:Humans
  5. Malik AA, Becerra MC, Lash TL, Cranmer LM, Omer SB, Fuad J, Siddiqui S, Amanullah F, Jaswal M, Salahuddin N, Keshavjee S, Hussain H, Gandhi NR. Risk Factors for Adverse Events in Household Contacts Prescribed Preventive Treatment for Drug-resistant Tuberculosis Exposure. Clin Infect Dis. 2021 05 18; 72(10):1709-1715. PMID: 32266942.
    Citations: 2     Fields:    Translation:Humans
  6. Mantena S, Celi LA, Keshavjee S, Beratarrechea A. Improving community health-care screenings with smartphone-based AI technologies. Lancet Digit Health. 2021 05; 3(5):e280-e282. PMID: 33890577.
    Citations:    Translation:HumansPHPublic Health
  7. Knipper M, Sedas AC, Keshavjee S, Abbara A, Almhawish N, Alashawi H, Lecca L, Wilson M, Zumla A, Abubakar I, Orcutt M. The need for protecting and enhancing TB health policies and services for forcibly displaced and migrant populations during the ongoing COVID-19 pandemic. Int J Infect Dis. 2021 Mar 26. PMID: 33775886.
    Citations:    Fields:    
  8. Malik AA, Farooq S, Jaswal M, Khan H, Nasir K, Fareed U, Shahbaz S, Amanullah F, Safdar N, Khan AJ, Keshavjee S, Becerra MC, Hussain H. Safety and feasibility of 1 month of daily rifapentine plus isoniazid to prevent tuberculosis in children and adolescents: a prospective cohort study. Lancet Child Adolesc Health. 2021 05; 5(5):350-356. PMID: 33770510.
    Citations: 1     Fields:    Translation:Humans
  9. Barsky BA, Reinhart E, Farmer P, Keshavjee S. Vaccination plus Decarceration - Stopping Covid-19 in Jails and Prisons. N Engl J Med. 2021 Apr 29; 384(17):1583-1585. PMID: 33657290.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  10. Malik AA, Gandhi NR, Lash TL, Cranmer LM, Omer SB, Ahmed JF, Siddiqui S, Amanullah F, Khan AJ, Keshavjee S, Hussain H, Becerra MC. Effectiveness of Preventive Therapy for Persons Exposed at Home to Drug-Resistant Tuberculosis, Karachi, Pakistan. Emerg Infect Dis. 2021 03; 27(3):805-812. PMID: 33624580.
    Citations: 1     Fields:    Translation:HumansCells
  11. Yuen CM, Millones AK, Puma D, Jimenez J, Galea JT, Calderon R, Pages GS, Brooks MB, Lecca L, Nicholson T, Becerra MC, Keshavjee S. Closing delivery gaps in the treatment of tuberculosis infection: Lessons from implementation research in Peru. PLoS One. 2021; 16(2):e0247411. PMID: 33606824.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  12. Yuen CM, Millones AK, Galea JT, Puma D, Jimenez J, Lecca L, Becerra MC, Keshavjee S. Toward patient-centered tuberculosis preventive treatment: preferences for regimens and formulations in Lima, Peru. BMC Public Health. 2021 01 11; 21(1):121. PMID: 33430823.
    Citations: 1     Fields:    Translation:Humans
  13. Burzynski J, Keshavjee S. Supporting a Comprehensive International Approach to Global Tuberculosis Eradication Is the Right Thing to Do. Am J Respir Crit Care Med. 2020 12 01; 202(11):1499-1500. PMID: 32835503.
    Citations:    Fields:    Translation:Humans
  14. Kim J, Keshavjee S, Atun R. Trends, patterns and health consequences of multimorbidity among South Korea adults: Analysis of nationally representative survey data 2007-2016. J Glob Health. 2020 Dec; 10(2):020426. PMID: 33274065.
    Citations: 2     Fields:    Translation:Humans
  15. Mistry N, Hemler EC, Dholakia Y, Bromage S, Shukla A, Dev P, Govekar L, Tipre P, Shah D, Keshavjee SA, Fawzi WW. Protocol for a case-control study of vitamin D status, adult multidrug-resistant tuberculosis disease and tuberculosis infection in Mumbai, India. BMJ Open. 2020 11 12; 10(11):e039935. PMID: 33184081.
    Citations: 1     Fields:    Translation:Humans
  16. Yuen CM, Seddon JA, Keshavjee S, Dodd PJ. Risk-benefit analysis of tuberculosis infection testing for household contact management in high-burden countries: a mathematical modelling study. Lancet Glob Health. 2020 05; 8(5):e672-e680. PMID: 32353315.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  17. Malik AA, Fuad J, Siddiqui S, Amanullah F, Jaswal M, Barry Z, Jabeen F, Fatima R, Yuen CM, Salahuddin N, Khan AJ, Keshavjee S, Becerra MC, Hussain H. Tuberculosis Preventive Therapy for Individuals Exposed to Drug-resistant Tuberculosis: Feasibility and Safety of a Community-based Delivery of Fluoroquinolone-containing Preventive Regimen. Clin Infect Dis. 2020 04 15; 70(9):1958-1965. PMID: 31190072.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  18. Kim J, Haacker M, Keshavjee S, Atun R. Cost-effectiveness of scaling up of hepatitis C screening and treatment: a modelling study in South Korea. BMJ Glob Health. 2019; 4(3):e001441. PMID: 31263587.
    Citations:    
  19. Kim J, Keshavjee S, Atun R. Health systems performance in managing tuberculosis: analysis of tuberculosis care cascades among high-burden and non-high-burden countries. J Glob Health. 2019 Jun; 9(1):010423. PMID: 31263546.
    Citations: 6     Fields:    Translation:Humans
  20. Yuen CM, Millones AK, Contreras CC, Lecca L, Becerra MC, Keshavjee S. Tuberculosis household accompaniment to improve the contact management cascade: A prospective cohort study. PLoS One. 2019; 14(5):e0217104. PMID: 31100097.
    Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
  21. Keshavjee S, Amanullah F, Cattamanchi A, Chaisson R, Dobos KM, Fox GJ, Gendelman HE, Gordon R, Hesseling A, Le Van H, Kampmann B, Kana B, Khuller G, Lewinsohn DM, Lewinsohn DA, Lin PL, Lu LL, Maartens G, Owen A, Protopopova M, Rengarajan J, Rubin E, Salgame P, Schurr E, Seddon JA, Swindells S, Tobin DM, Udwadia Z, Walzl G, Srinivasan S, Rustomjee R, Nahid P. Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection. Am J Respir Crit Care Med. 2019 03 01; 199(5):564-571. PMID: 30335466.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  22. Brooks MB, Keshavjee S, Gelmanova I, Zemlyanaya NA, Mitnick CD, Manjourides J. Use of predicted vital status to improve survival analysis of multidrug-resistant tuberculosis cohorts. BMC Med Res Methodol. 2018 12 11; 18(1):166. PMID: 30537944.
    Citations: 2     Fields:    Translation:Humans
  23. Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P, Bang D, Barry PM, Bastos ML, Behera D, Benedetti A, Bisson GP, Boeree MJ, Bonnet M, Brode SK, Brust JCM, Cai Y, Caumes E, Cegielski JP, Centis R, Chan PC, Chan ED, Chang KC, Charles M, Cirule A, Dalcolmo MP, D'Ambrosio L, de Vries G, Dheda K, Esmail A, Flood J, Fox GJ, Fréchet-Jachym M, Fregona G, Gayoso R, Gegia M, Gler MT, Gu S, Guglielmetti L, Holtz TH, Hughes J, Isaakidis P, Jarlsberg L, Kempker RR, Keshavjee S, Khan FA, Kipiani M, Koenig SP, Koh WJ, Kritski A, Kuksa L, Kvasnovsky CL, Kwak N, Lan Z, Lange C, Laniado-Laborín R, Lee M, Leimane V, Leung CC, Leung EC, Li PZ, Lowenthal P, Maciel EL, Marks SM, Mase S, Mbuagbaw L, Migliori GB, Milanov V, Miller AC, Mitnick CD, Modongo C, Mohr E, Monedero I, Nahid P, Ndjeka N, O'Donnell MR, Padayatchi N, Palmero D, Pape JW, Podewils LJ, Reynolds I, Riekstina V, Robert J, Rodriguez M, Seaworth B, Seung KJ, Schnippel K, Shim TS, Singla R, Smith SE, Sotgiu G, Sukhbaatar G, Tabarsi P, Tiberi S, Trajman A, Trieu L, Udwadia ZF, van der Werf TS, Veziris N, Viiklepp P, Vilbrun SC, Walsh K, Westenhouse J, Yew WW, Yim JJ, Zetola NM, Zignol M, Menzies D. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet. 2018 09 08; 392(10150):821-834. PMID: 30215381.
    Citations: 98     Fields:    Translation:Humans
  24. Miller AC, Livchits V, Ahmad Khan F, Atwood S, Kornienko S, Kononenko Y, Vasilyeva I, Keshavjee S. Turning Off the Tap: Using the FAST Approach to Stop the Spread of Drug-Resistant Tuberculosis in the Russian Federation. J Infect Dis. 2018 07 13; 218(4):654-658. PMID: 29659912.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  25. Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016 10 01; 63(7):853-67. PMID: 27621353.
    Citations: 53     Fields:    Translation:HumansCellsPHPublic Health
  26. Mitnick CD, White RA, Lu C, Rodriguez CA, Bayona J, Becerra MC, Burgos M, Centis R, Cohen T, Cox H, D'Ambrosio L, Danilovitz M, Falzon D, Gelmanova IY, Gler MT, Grinsdale JA, Holtz TH, Keshavjee S, Leimane V, Menzies D, Migliori GB, Milstein MB, Mishustin SP, Pagano M, Quelapio MI, Shean K, Shin SS, Tolman AW, van der Walt ML, Van Deun A, Viiklepp P. Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method. Eur Respir J. 2016 10; 48(4):1160-1170. PMID: 27587552.
    Citations: 10     Fields:    Translation:HumansCells
  27. Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016 10 01; 63(7):e147-e195. PMID: 27516382.
    Citations: 187     Fields:    Translation:HumansCellsPHPublic Health
  28. Shakow, A., Admay,C., Nicholson, T., Keshavjee, S. Double Standards in Global Health: Medicine, Human Rights Law and Multidrug-Resistant TB Treatment Policy. Health and Human Rights Journal. 2016; 18(1):85-101. View Publication.
  29. Nicholson T, Admay C, Shakow A, Keshavjee S. Double Standards in Global Health: Medicine, Human Rights Law and Multidrug-Resistant TB Treatment Policy. Health Hum Rights. 2016 Jun; 18(1):85-102. PMID: 27781001.
    Citations: 5     Fields:    Translation:Humans
  30. Ahmad Khan F, Gelmanova IY, Franke MF, Atwood S, Zemlyanaya NA, Unakova IA, Andreev YG, Berezina VI, Pavlova VE, Shin SS, Yedilbayev AB, Becerra MC, Keshavjee S. Aggressive Regimens Reduce Risk of Recurrence After Successful Treatment of MDR-TB. Clin Infect Dis. 2016 07 15; 63(2):214-20. PMID: 27161772.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  31. Fox GJ, Mitnick CD, Benedetti A, Chan ED, Becerra M, Chiang CY, Keshavjee S, Koh WJ, Shiraishi Y, Viiklepp P, Yim JJ, Pasvol G, Robert J, Shim TS, Shin SS, Menzies D, Ahuja S, Ashkin D, Avendaño M, Banerjee R, Bauer M, Burgos M, Centis R, Cobelens F, Cox H, D'Ambrosio L, de Lange WCM, DeRiemer K, Enarson D, Falzon D, Flanagan K, Flood J, Gandhi N, Garcia-Garcia L, Granich RM, Hollm-Delgado MG, Holtz TH, Hopewell P, Iseman M, Jarlsberg LG, Kim HR, Lancaster J, Lange C, Leimane V, Leung CC, Li J, Menzies D, Migliori GB, Narita M, Nathanson E, Odendaal R, O'Riordan P, Pai M, Palmero D, Park SK, Pena J, Pérez-Guzmán C, Ponce-de-Leon A, Quelapio MID, Quy HT, Riekstina V, Royce S, Salim M, Schaaf HS, Seung KJ, Shah L, Shean K, Sifuentes-Osornio J, Sotgiu G, Strand MJ, Sung SW, Tabarsi P, Tupasi TE, Vargas MH, van Altena R, van der Walt M, van der Werf TS, Westenhouse J, Yew WW. Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis. Clin Infect Dis. 2016 Apr 01; 62(7):887-895. PMID: 26757804.
    Citations: 16     Fields:    Translation:Humans
  32. Yuen CM, Amanullah F, Dharmadhikari A, Nardell EA, Seddon JA, Vasilyeva I, Zhao Y, Keshavjee S, Becerra MC. Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment. Lancet. 2015 Dec 05; 386(10010):2334-43. PMID: 26515675.
    Citations: 46     Fields:    Translation:HumansPHPublic Health
  33. Keshavjee S, Dowdy D, Swaminathan S. Stopping the body count: a comprehensive approach to move towards zero tuberculosis deaths. Lancet. 2015 Dec 05; 386(10010):e46-7. PMID: 26515680.
    Citations: 11     Fields:    Translation:HumansPHPublic Health
  34. Yuen CM, Jenkins HE, Rodriguez CA, Keshavjee S, Becerra MC. Global and Regional Burden of Isoniazid-Resistant Tuberculosis. Pediatrics. 2015 Jul; 136(1):e50-9. PMID: 26034243.
    Citations: 7     Fields:    Translation:Humans
  35. Seung KJ, Keshavjee S, Rich ML. Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis. Cold Spring Harb Perspect Med. 2015 Apr 27; 5(9):a017863. PMID: 25918181.
    Citations: 45     Fields:    Translation:Humans
  36. Kurbatova EV, Cegielski JP, Lienhardt C, Akksilp R, Bayona J, Becerra MC, Caoili J, Contreras C, Dalton T, Danilovits M, Demikhova OV, Ershova J, Gammino VM, Gelmanova I, Heilig CM, Jou R, Kazennyy B, Keshavjee S, Kim HJ, Kliiman K, Kvasnovsky C, Leimane V, Mitnick CD, Quelapio I, Riekstina V, Smith SE, Tupasi T, van der Walt M, Vasilyeva IA, Via LE, Viiklepp P, Volchenkov G, Walker AT, Wolfgang M, Yagui M, Zignol M. Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies. Lancet Respir Med. 2015 Mar; 3(3):201-9. PMID: 25726085.
    Citations: 47     Fields:    Translation:HumansCells
  37. Hwang TJ, Keshavjee S. Global financing and long-term technical assistance for multidrug-resistant tuberculosis: scaling up access to treatment. PLoS Med. 2014 Sep; 11(9):e1001738. PMID: 25268235.
    Citations: 2     Fields:    Translation:Humans
  38. Berkelman RL, Cassell GH, Whitney EA, Keshavjee S. Shifting gears to control drug-resistant tuberculosis. Clin Infect Dis. 2014 Sep 15; 59(6):908-10. PMID: 24944229.
    Citations: 1     Fields:    Translation:Humans
  39. Velásquez GE, Becerra MC, Gelmanova IY, Pasechnikov AD, Yedilbayev A, Shin SS, Andreev YG, Yanova G, Atwood SS, Mitnick CD, Franke MF, Rich ML, Keshavjee S. Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death. Clin Infect Dis. 2014 Jul 01; 59(1):9-15. PMID: 24729493.
    Citations: 22     Fields:    Translation:HumansCells
  40. Jenkins HE, Tolman AW, Yuen CM, Parr JB, Keshavjee S, Pérez-Vélez CM, Pagano M, Becerra MC, Cohen T. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet. 2014 May 03; 383(9928):1572-9. PMID: 24671080.
    Citations: 82     Fields:    Translation:Humans
  41. Lessem E, Keshavjee S. Russia: Drug-resistant TB can be contained. Nature. 2014 Feb 20; 506(7488):295. PMID: 24553229.
    Citations: 3     Fields:    Translation:Humans
  42. Hwang TJ, Dotsenko S, Jafarov A, Weyer K, Falzon D, Lunte K, Nunn P, Jaramillo E, Keshavjee S, Wares DF. Safety and availability of clofazimine in the treatment of multidrug and extensively drug-resistant tuberculosis: analysis of published guidance and meta-analysis of cohort studies. BMJ Open. 2014 Jan 02; 4(1):e004143. PMID: 24384902.
    Citations: 14     Fields:    Translation:Humans
  43. Yuen CM, Tolman AW, Cohen T, Parr JB, Keshavjee S, Becerra MC. Isoniazid-resistant tuberculosis in children: a systematic review. Pediatr Infect Dis J. 2013 May; 32(5):e217-26. PMID: 23348808.
    Citations: 8     Fields:    Translation:HumansCells
  44. Keshavjee S, Farmer PE. History of tuberculosis and drug resistance. N Engl J Med. 2013 01 03; 368(1):89-90. PMID: 23281995.
    Citations: 1     Fields:    Translation:Humans
  45. Dharmadhikari A, Smith J, Nardell E, Churchyard G, Keshavjee S. Aspiring to zero tuberculosis deaths among southern Africa's miners: is there a way forward? Int J Health Serv. 2013; 43(4):651-64. PMID: 24397232.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  46. Falzon D, Gandhi N, Migliori GB, Sotgiu G, Cox HS, Holtz TH, Hollm-Delgado MG, Keshavjee S, DeRiemer K, Centis R, D'Ambrosio L, Lange CG, Bauer M, Menzies D. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur Respir J. 2013 Jul; 42(1):156-68. PMID: 23100499.
    Citations: 106     Fields:    Translation:HumansCells
  47. Migliori GB, Sotgiu G, Gandhi NR, Falzon D, DeRiemer K, Centis R, Hollm-Delgado MG, Palmero D, Pérez-Guzmán C, Vargas MH, D'Ambrosio L, Spanevello A, Bauer M, Chan ED, Schaaf HS, Keshavjee S, Holtz TH, Menzies D. Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis. Eur Respir J. 2013 Jul; 42(1):169-179. PMID: 23060633.
    Citations: 54     Fields:    Translation:HumansCells
  48. Keshavjee S, Farmer PE. Tuberculosis, drug resistance, and the history of modern medicine. N Engl J Med. 2012 Sep 06; 367(10):931-6. PMID: 22931261.
    Citations: 62     Fields:    Translation:HumansCellsPHPublic Health
  49. Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, Becerra MC, Benedetti A, Burgos M, Centis R, Chan ED, Chiang CY, Cox H, D'Ambrosio L, DeRiemer K, Dung NH, Enarson D, Falzon D, Flanagan K, Flood J, Garcia-Garcia ML, Gandhi N, Granich RM, Hollm-Delgado MG, Holtz TH, Iseman MD, Jarlsberg LG, Keshavjee S, Kim HR, Koh WJ, Lancaster J, Lange C, de Lange WC, Leimane V, Leung CC, Li J, Menzies D, Migliori GB, Mishustin SP, Mitnick CD, Narita M, O'Riordan P, Pai M, Palmero D, Park SK, Pasvol G, Peña J, Pérez-Guzmán C, Quelapio MI, Ponce-de-Leon A, Riekstina V, Robert J, Royce S, Schaaf HS, Seung KJ, Shah L, Shim TS, Shin SS, Shiraishi Y, Sifuentes-Osornio J, Sotgiu G, Strand MJ, Tabarsi P, Tupasi TE, van Altena R, Van der Walt M, Van der Werf TS, Vargas MH, Viiklepp P, Westenhouse J, Yew WW, Yim JJ. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med. 2012; 9(8):e1001300. PMID: 22952439.
    Citations: 176     Fields:    Translation:Humans
  50. Kurbatova EV, Taylor A, Gammino VM, Bayona J, Becerra M, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Viiklepp P, Zignol M, Cegielski JP. Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects. Tuberculosis (Edinb). 2012 Sep; 92(5):397-403. PMID: 22789497.
    Citations: 52     Fields:    Translation:Humans
  51. Khan AJ, Khowaja S, Khan FS, Qazi F, Lotia I, Habib A, Mohammed S, Khan U, Amanullah F, Hussain H, Becerra MC, Creswell J, Keshavjee S. Engaging the private sector to increase tuberculosis case detection: an impact evaluation study. Lancet Infect Dis. 2012 Aug; 12(8):608-16. PMID: 22704778.
    Citations: 61     Fields:    Translation:HumansPHPublic Health
  52. Satti H, McLaughlin MM, Omotayo DB, Keshavjee S, Becerra MC, Mukherjee JS, Seung KJ. Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence. PLoS One. 2012; 7(5):e37114. PMID: 22629356.
    Citations: 10     Fields:    Translation:Humans
  53. Keshavjee S, Gelmanova IY, Shin SS, Mishustin SP, Andreev YG, Atwood S, Furin JJ, Miller A. Hepatotoxicity during treatment for multidrug-resistant tuberculosis: occurrence, management and outcome. Int J Tuberc Lung Dis. 2012 May; 16(5):596-603. PMID: 22410436.
    Citations: 7     Fields:    Translation:Humans
  54. Floyd K, Hutubessy R, Kliiman K, Centis R, Khurieva N, Jakobowiak W, Danilovits M, Peremitin G, Keshavjee S, Migliori GB. Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia. Eur Respir J. 2012 Jul; 40(1):133-42. PMID: 22362862.
    Citations: 15     Fields:    Translation:Humans
  55. Furin J, Gegia M, Mitnick C, Rich M, Shin S, Becerra M, Drobac P, Farmer P, Hurtado R, Joseph JK, Keshavjee S, Kalandadze I. Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experience. Bull World Health Organ. 2012 Jan 01; 90(1):63-6. PMID: 22271966.
    Citations: 11     Fields:    Translation:HumansPHPublic Health
  56. Keshavjee S, Harrington M, Gonsalves G, Chesire L, Farmer PE. Time for zero deaths from tuberculosis. Lancet. 2011 Oct 22; 378(9801):1449-50. PMID: 22018005.
    Citations: 5     Fields:    Translation:Humans
  57. Furin J, Bayona J, Becerra M, Farmer P, Golubkov A, Hurtado R, Joseph JK, Keshavjee S, Ponomarenko O, Rich M, Shin S. Programmatic management of multidrug-resistant tuberculosis: models from three countries. Int J Tuberc Lung Dis. 2011 Oct; 15(10):1294-300. PMID: 21669029.
    Citations: 9     Fields:    Translation:Humans
  58. Keshavjee S, Farmer P. In reply to '"Universal" access for MDR-TB limited without the involvement of the private sector' [Correspondence]. Int J Tuberc Lung Dis. 2011 Jun 01; 15(6):851-852. PMID: 29070322.
    Citations:    
  59. Cox H, Ford N, Keshavjee S, McDermid C, von Schoen-Angerer T, Mitnick C, Goemaere E. Rational use of moxifloxacin for tuberculosis treatment. Lancet Infect Dis. 2011 Apr; 11(4):259-60. PMID: 21453864.
    Citations: 5     Fields:    Translation:HumansCells
  60. Keshavjee S, Farmer PE. Picking up the pace--scale-up of MDR tuberculosis treatment programs. N Engl J Med. 2010 Nov 04; 363(19):1781-4. PMID: 21047219.
    Citations: 21     Fields:    Translation:HumansPHPublic Health
  61. Keshavjee S, Girard F, Harrington M, Farmer PE. Time for a bold new vision at the Stop TB Partnership. Lancet. 2010 Oct 16; 376(9749):1283-4. PMID: 20951876.
    Citations:    Fields:    Translation:Humans
  62. Shin SS, Keshavjee S, Gelmanova IY, Atwood S, Franke MF, Mishustin SP, Strelis AK, Andreev YG, Pasechnikov AD, Barnashov A, Tonkel TP, Cohen T. Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment. Am J Respir Crit Care Med. 2010 Aug 01; 182(3):426-32. PMID: 20413630.
    Citations: 32     Fields:    Translation:Humans
  63. Seung KJ, Omatayo DB, Keshavjee S, Furin JJ, Farmer PE, Satti H. Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa. PLoS One. 2009 Sep 25; 4(9):e7186. PMID: 19779624.
    Citations: 48     Fields:    Translation:HumansCells
  64. Keshavjee S, Gelmanova IY, Farmer PE, Mishustin SP, Strelis AK, Andreev YG, Pasechnikov AD, Atwood S, Mukherjee JS, Rich ML, Furin JJ, Nardell EA, Kim JY, Shin SS. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet. 2008 Oct 18; 372(9647):1403-9. PMID: 18723218.
    Citations: 59     Fields:    Translation:Humans
  65. Satti H, Seung K, Keshavjee S, Furin J. Extensively drug-resistant tuberculosis, Lesotho. Emerg Infect Dis. 2008 Jun; 14(6):992-3. PMID: 18551748.
    Citations: 7     Fields:    Translation:HumansCells
  66. Furin J, Shutts M, Keshavjee S. Aviation and the delivery of medical care in remote regions: the Lesotho HIV experience. Aviat Space Environ Med. 2008 Feb; 79(2):136-8. PMID: 18309912.
    Citations: 1     Fields:    Translation:Humans
  67. Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, Tonkel TP, Yanova GV, Yedilbayev A, Rich ML, Mukherjee JS, Furin JJ, Atwood S, Farmer PE, Keshavjee S. Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia. Int J Tuberc Lung Dis. 2007 Dec; 11(12):1314-20. PMID: 18034952.
    Citations: 38     Fields:    Translation:Humans
  68. Keshavjee S, Gelmanova IY, Pasechnikov AD, Mishustin SP, Andreev YG, Yedilbayev A, Furin JJ, Mukherjee JS, Rich ML, Nardell EA, Farmer PE, Kim JY, Shin SS. Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease. Ann N Y Acad Sci. 2008; 1136:1-11. PMID: 17954675.
    Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
  69. Furin JJ, Behforouz HL, Shin SS, Mukherjee JS, Bayona J, Farmer PE, Kim JY, Keshavjee S. Expanding global HIV treatment: case studies from the field. Ann N Y Acad Sci. 2008; 1136:12-20. PMID: 17954668.
    Citations: 7     Fields:    Translation:Humans
  70. Furin JJ, Rigodon J, Cancedda C, Keshavjee S, Seung KJ, Letsie M, Kim JY, Joseph JK. Improved case detection of active tuberculosis associated with an antiretroviral treatment program in Lesotho. Int J Tuberc Lung Dis. 2007 Oct; 11(10):1154-6. PMID: 17945074.
    Citations: 3     Fields:    Translation:Humans
  71. Farmer PE, Nizeye B, Stulac S, Keshavjee S. Structural violence and clinical medicine. PLoS Med. 2006 Oct; 3(10):e449. PMID: 17076568.
    Citations: 132     Fields:    Translation:HumansPHPublic Health
  72. Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, Tonkel TP, Yanova GV, Nikiforov M, Yedilbayev A, Mukherjee JS, Furin JJ, Barry DJ, Farmer PE, Rich ML, Keshavjee S. Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. Int J Tuberc Lung Dis. 2006 Apr; 10(4):402-8. PMID: 16602404.
    Citations: 40     Fields:    Translation:Humans
  73. Keshavjee S. Bleeding babies in Badakhshan. Symbolism, materialism, and the political economy of traditional medicine in post-Soviet Tajikistan. Med Anthropol Q. 2006 Mar; 20(1):72-93. PMID: 16612994.
    Citations:    Fields:    Translation:Humans
  74. Keshavjee S. Bleeding babies in Badakhshan: symbolism, materialism, and the political economy of traditional medicine in post-Soviet Tajikistan. Medical Anthropology Quarterly,(in press). 2005.
  75. Shin SS, Pasechnikov AD, Rich ML, Gelmanova IY, Yarosh OA, Peremitin GG, Andreev YG, Yedilbaev Y, Mukherjee J, Barry D, Ponomarenko OI, Nikiforov MI, Farmer PE. Treatment of alcoholic individuals with MDR-TB in Tomsk, Russia. IUATLD World Conference on Lung Health, Paris, France. 2004.
  76. Keshavjee S, Gelmanova IY, Peremitin GG, Golubchikova VT, Tonkel TP, Rich ML, Pasechnikov AD, Yedilbaev A, Mukherjee J, Barry D, Ponomarenko OI, Nikiforov MI, Farmer PE, Shin S. Using DOTS-Plus to improve DOTS and expand access to effective tuberculosis treatment in Tomsk Oblast, Russia. IUATLD World Conference on Lung Health, Paris, France. 2004.
  77. Keshavjee S, Peremitin GG, Pasechnikov AD, Golubchikova VT, Tonkel TP, Yedilbayev A, Shin S, Rich ML, Mukherjee J, Barry D, Ponomarenko OI, Farmer PE, Gelmanova IY. Community based treatment of MDR-TB in Tomsk Oblast, Russia: using DOTS-Plus to improve and expand access to DOTS. IUATLD European Region Meeting, Moscow, Russia. 2004.
  78. Keshavjee S. Medicine and money: the ethical transformation of medical practice. Med Educ. 2004 Mar; 38(3):271-5. PMID: 14996336.
    Citations: 1     Fields:    Translation:Humans
  79. Keshavjee S. The contradictions of a revolving drug fund in post-Soviet Tajikistan: selling medicines to starving patients. Castro A, Merrill S, editors. Unhealthy health policy: a critical anthropological examination. 2004; 97-114.
  80. Keshavjee S, Weiser S, Kleinman A. Medicine betrayed: hemophilia patients and HIV in the US. Soc Sci Med. 2001 Oct; 53(8):1081-94. PMID: 11556777.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  81. Keshavjee S. A doctor’s view of medicine and misery. MS-JAMA online Link: http://www.ama-assn.org/sci-pubs/msjama/articles/vol_285/no_9/keshavjee.ht . 2001; 285(9).
  82. Madill J, Gutierrez C, Grossman J, Allard J, Chan C, Hutcheon M, Keshavjee SH. Nutritional assessment of the lung transplant patient: body mass index as a predictor of 90-day mortality following transplantation. J Heart Lung Transplant. 2001 Mar; 20(3):288-96. PMID: 11257554.
    Citations: 14     Fields:    Translation:Humans
  83. Keshavjee S, Becerra MC. Disintegrating health services and resurgent tuberculosis in post-Soviet Tajikistan: an example of structural violence. JAMA. 2000 Mar 01; 283(9):1201. PMID: 10703788.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  84. Keshavjee, S. Medicines and transitions: the political economy of health and social change in post-Soviet Badakhshan, Tajikistan. 1998.
  85. Keshavjee S. Medical anthropology: insights into the social, political, and economic determinants of health. JAMA. 1996 Oct 02; 276(13):1096-7. PMID: 8847775.
    Citations:    Fields:    
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Keshavjee's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (246)
Explore
_
Co-Authors (35)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.